BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23851616)

  • 1. Avastin exhibits therapeutic effects on collagen-induced arthritis in rat model.
    Wang Y; Da G; Li H; Zheng Y
    Inflammation; 2013 Dec; 36(6):1460-7. PubMed ID: 23851616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subconjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization.
    Ozdemir O; Altintas O; Altintas L; Yildiz DK; Sener E; Caglar Y
    Can J Ophthalmol; 2013 Apr; 48(2):115-20. PubMed ID: 23561605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of lactosyl derivative Gu-4 in a collagen-induced arthritis rat model.
    Fan J; Zhou H; Wang S; Wang H; Zhang Y; Guo Y; Li Q; Li Z; Zhao Z
    Glycoconj J; 2012 Aug; 29(5-6):305-13. PubMed ID: 22688516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of dimethyl dimethoxy biphenyl dicarboxylate on collagen-induced arthritis in rats.
    Talaat RM; Abo-El-Atta AS; Farou SM; El-Dosoky KI
    Chin J Integr Med; 2015 Nov; 21(11):846-54. PubMed ID: 24584757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intra-articular injection of different concentrations of ozone on the level of TNF-α, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis.
    Chen H; Yu B; Lu C; Lin Q
    Rheumatol Int; 2013 May; 33(5):1223-7. PubMed ID: 23052485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-antiangiogenic protein DAAP targeting vascular endothelial growth factor A and angiopoietins attenuates collagen-induced arthritis.
    Hah YS; Koh YJ; Lim HS; Kim HO; Cheon YH; Noh HS; Jang KY; Lee SY; Lee GM; Koh GY; Lee SI
    Arthritis Res Ther; 2013 Aug; 15(4):R85. PubMed ID: 23945080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model.
    Setoguchi C; Tsuji F; Katsuta O; Okamoto M; Aono H
    Mod Rheumatol; 2010 Aug; 20(4):381-8. PubMed ID: 20379758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept marketed for moderate, severe rheumatoid arthritis.
    Am J Health Syst Pharm; 1998 Dec; 55(24):2593. PubMed ID: 9872697
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis.
    Hsu YH; Chang MS
    Arthritis Rheum; 2010 Nov; 62(11):3311-21. PubMed ID: 20722035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept: a review of its use in rheumatoid arthritis.
    Jarvis B; Faulds D
    Drugs; 1999 Jun; 57(6):945-66. PubMed ID: 10400407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.
    Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS
    Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancolitis during etanercept treatment of rheumatoid arthritis relapsing on the administration of further two TNF-alpha inhibitors.
    Actis GC; Lagget M; Pellicano R; Rosina F
    Int J Colorectal Dis; 2012 Apr; 27(4):547-8. PubMed ID: 21656142
    [No Abstract]   [Full Text] [Related]  

  • 15. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing outcomes in rheumatoid arthritis.
    Small RE; Schuna A
    J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S16-7. PubMed ID: 14626516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?
    Nagashima T; Minota S
    Clin Rheumatol; 2010 Jul; 29(7):819-20. PubMed ID: 20405301
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced production of anti-etanercept antibody in collagen-induced arthritis.
    Yi H; Kim J; Jung H; Rim YA; Kim Y; Jung SM; Park SH; Ju JH
    Mol Med Rep; 2014 Jun; 9(6):2301-8. PubMed ID: 24718553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis.
    Moreland LW
    Cleve Clin J Med; 1999 Jun; 66(6):367-74. PubMed ID: 10375846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.